BR112022014093A2 - Reagente de diagnóstico para determinação quantitativa de procalcitonina em uma amostra - Google Patents

Reagente de diagnóstico para determinação quantitativa de procalcitonina em uma amostra

Info

Publication number
BR112022014093A2
BR112022014093A2 BR112022014093A BR112022014093A BR112022014093A2 BR 112022014093 A2 BR112022014093 A2 BR 112022014093A2 BR 112022014093 A BR112022014093 A BR 112022014093A BR 112022014093 A BR112022014093 A BR 112022014093A BR 112022014093 A2 BR112022014093 A2 BR 112022014093A2
Authority
BR
Brazil
Prior art keywords
procalcitonin
sample
quantitative determination
suspension
diagnostic reagent
Prior art date
Application number
BR112022014093A
Other languages
English (en)
Inventor
Grimmler Matthias
Masetto Thomas
Original Assignee
Diasys Diagnostic Systems Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diasys Diagnostic Systems Gmbh filed Critical Diasys Diagnostic Systems Gmbh
Publication of BR112022014093A2 publication Critical patent/BR112022014093A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/585Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

REAGENTE DE DIAGNÓSTICO PARA DETERMINAÇÃO QUANTITATIVA DE PROCALCITONINA EM UMA AMOSTRA. De modo a fornecer um reagente de diagnóstico adequado para análise turbidimétrica com um fotômetro simples e com alta sensibilidade para determinação quantitativa da procalcitonina em uma amostra, em que o reagente é uma suspensão aquosa de partículas de polímero com anticorpos contra a procalcitonina covalentemente ligada a essas partículas de polímero, no qual não é detectável nenhuma ou apenas uma tendência extremamente leve à aglutinação/sedimentação, mesmo após tempos mais longos e a reatividade específica das partículas permanece em grande parte inalterada, propõe-se, de acordo com a invenção, que as partículas de polímero em suspensão tenham um tamanho médio de partícula na faixa de 150 a 450 nm, a suspensão compreende uma proporção de açúcar ou álcool de açúcar dissolvido na faixa de 25 a 250 g/l e a suspensão tem um pH na faixa de 8 a 10.
BR112022014093A 2020-01-28 2021-01-25 Reagente de diagnóstico para determinação quantitativa de procalcitonina em uma amostra BR112022014093A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020102038 2020-01-28
PCT/EP2021/051577 WO2021151820A1 (de) 2020-01-28 2021-01-25 Diagnostisches reagenz zur quantitativen bestimmung von procalcitonin in einer probe

Publications (1)

Publication Number Publication Date
BR112022014093A2 true BR112022014093A2 (pt) 2022-09-13

Family

ID=74550606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022014093A BR112022014093A2 (pt) 2020-01-28 2021-01-25 Reagente de diagnóstico para determinação quantitativa de procalcitonina em uma amostra

Country Status (7)

Country Link
US (1) US20230083766A1 (pt)
EP (1) EP4097476A1 (pt)
JP (1) JP2023514969A (pt)
KR (1) KR20220133225A (pt)
CN (1) CN115210569A (pt)
BR (1) BR112022014093A2 (pt)
WO (1) WO2021151820A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE356874T1 (de) 1999-12-22 2007-04-15 Dade Behring Marburg Gmbh Lösungen von humanem procalcitonin
CN103558400A (zh) * 2013-11-25 2014-02-05 重庆中元生物技术有限公司 一种降钙素原乳胶增强免疫比浊法检测试剂盒
CN105891497A (zh) * 2014-12-19 2016-08-24 北京科美生物技术有限公司 一种降钙素原胶体金免疫比色法定量检测试剂盒及其制备方法
CN109725160B (zh) * 2018-12-30 2021-03-23 山东博科生物产业有限公司 一种降钙素原(pct)检测试剂盒
CN109959797A (zh) * 2019-03-28 2019-07-02 曾宪亮 一种降钙素原检测试剂盒及其制备方法

Also Published As

Publication number Publication date
EP4097476A1 (de) 2022-12-07
WO2021151820A1 (de) 2021-08-05
KR20220133225A (ko) 2022-10-04
US20230083766A1 (en) 2023-03-16
CN115210569A (zh) 2022-10-18
JP2023514969A (ja) 2023-04-12

Similar Documents

Publication Publication Date Title
Aho et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
ES2707073T3 (es) Enfoque de aplicación múltiple para la determinación fotométrica de un analito en una muestra de fluido en un analizador automatizado
Sun et al. A sensitive and selective resonance light scattering bioassay for homocysteine in biological fluids based on target-involved assembly of polyethyleneimine-capped Ag-nanoclusters
Morin Direct colorimetric determination of serum calcium with o-cresolphthalein complexon
CN102590524A (zh) 中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒
Gao et al. Quantification of water-soluble vitamins in milk-based infant formulae using biosensor-based assays
Neun et al. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays
Peters et al. Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in Bangladesh
CN105556313A (zh) 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途
BR112012009291A2 (pt) sistema de reconhecimento de subenchimento para um biossensor
Rubio et al. Validation of an automated assay for the measurement of cupric reducing antioxidant capacity in serum of dogs
He et al. Detection of HIV-1 p24 antigen using streptavidin–biotin and gold nanoparticles based immunoassay by inductively coupled plasma mass spectrometry
LeWitt Recent advances in CSF biomarkers for Parkinson's disease
Dowling et al. Improved accuracy of an tandem liquid chromatography–mass spectrometry method measuring 24R, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D metabolites in serum using unspiked controls and its application to determining cross-reactivity of a chemiluminescent microparticle immunoassay
Rahman et al. A highly sensitive, simple, and fast gas chromatography–mass spectrometry method for the quantification of serum short-chain fatty acids and their potential features in central obesity
CN107356743B (zh) 一种用于检测肌红蛋白的测定试剂盒
Revendova et al. Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels
BR112022014093A2 (pt) Reagente de diagnóstico para determinação quantitativa de procalcitonina em uma amostra
Mastrovito et al. Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing
Donnelly et al. Evaluation of the Abbott IMxTM fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: Comparison with high-performance liquid chromatography
Pedro et al. An improved HPLC method for quantification of metanephrine with coulometric detection
Zhu et al. Self-assembled Mn-doped ZnSe quantum dot–methyl viologen nanohybrids as an OFF–ON fluorescent probe for time-resolved fluorescence detection of tiopronin
JP5541748B2 (ja) アビジン−ビオチン連結標識試薬を用いたイムノクロマトグラフ用試験具及びその利用
Enerbäck et al. Cytofluorometric quantitation of 5-hydroxytryptamine in mast cells: an improved technique for the formaldehyde condensation reaction.
Bilbrough et al. IDEXX Catalyst SDMA Test for in-house measurement of SDMA concentration in serum from dogs and cats